• INSUD PHARMA

    Covering all the links of the chemical-pharmaceutical industry. We have 3 business areas of action and a common base in R&D to develop new and better therapeutic solutions

  • INSUD PHARMA

    Covering all the links of the chemical-pharmaceutical industry. We have 3 business areas of action and a common base in R&D to develop new and better therapeutic solutions

The pharmaceutical industry is our initial activity, and the most important one, as it represents 80% of our revenues. It includes three companies: Chemo, the Group’s first company, focusing on the production of pharmaceutical ingredients and generics; Exeltis, a company that manufactures and markets branded medicines, and mAbxience, a producer of biosimilars.

In Argentina, we are shareholders of pharmaceutical companies Elea, Biogénesis Bagó, Sinergium Biotech, Maprimed, Chemotécnica S.A. and Inmunova.

Research, development and production of innovative medicines with the highest quality standards have been our main motivations from the start, and the driving forces behind our thriving global presence. 

Chemo

A global pharmaceutical company specializing in research, development, manufacturing, sale and marketing of active pharmaceutical ingredients (APIs), finished drug formulations (FDFs) and branded medicines, for human and veterinary use.

 

 

 

+

mAbxience

A company specializing in research, development and manufacturing of biotechnology medicines for disease treatment and/or prevention in a range of therapeutic areas.

 

 

+

Exeltis

Exeltis is the umbrella business name for the wide range of branded drugs associated with Chemo Company. It specializes in prescription drugs, with a strong focus on therapeutic lines including women’s health, respiratory diseases, oncology and dermatology.

+